American Money Management’s Biogen BIIB Stock Holding History

American Money Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,215	Closed	-$366K	–	77
2018 Q4	$366K	Hold	1,215	–	–	0.23%	60
2018 Q3	$429K	Hold	1,215	–	–	0.25%	60
2018 Q2	$353K	Hold	1,215	–	–	0.21%	60
2018 Q1	$333K	Sell	1,215 -35	-3%	-$10.9K	0.21%	58
2017 Q4	$398K	Hold	1,250	–	–	0.24%	58
2017 Q3	$391K	Sell	1,250 -80	-6%	-$23.7K	0.26%	58
2017 Q2	$361K	Sell	1,330 -19	-1%	-$5.02K	0.26%	60
2017 Q1	$369K	Buy	1,349 +14	+1%	+$3.96K	0.27%	60
2016 Q4	$379K	Sell	1,335 -195	-13%	-$57.8K	0.3%	58
2016 Q3	$479K	Buy	1,530 +25	+2%	+$7.4K	0.38%	52
2016 Q2	$364K	Buy	1,505 +65	+5%	+$17.1K	0.3%	59
2016 Q1	$375K	Sell	1,440 -10	-0.7%	-$2.64K	0.31%	57
2015 Q4	$444K	Sell	1,450 -305	-17%	-$87.6K	0.38%	55
2015 Q3	$512K	Buy	1,755 +105	+6%	+$34.7K	0.48%	52
2015 Q2	$667K	Buy	+1,650	New	+$662K	0.56%	49

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Money Management's BIIB Position: Q1 2019 in Review

American Money Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 1,215 shares — an estimated $366K sold.

American Money Management first reported a position in BIIB in Q2 2015 and held it in 15 quarters. The position peaked at $667K in Q2 2015. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

American Money Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
American Money Management sold 1,215 Biogen shares in Q1 2019, an estimated $366K.
American Money Management first reported a position in Biogen in Q2 2015 and held it in 15 quarters.
American Money Management's Biogen position peaked at $667K in Q2 2015.
1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on American Money Management's 13F filing for Q1 2019, filed 8 May 2019.